MIDU:ARCA-Direxion Mid Cap Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 55.86

Change

+1.08 (+1.97)%

Market Cap

USD 0.05B

Volume

0.23M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P MidCap? 400 Index. The fund, under normal circumstances, creates long positions by investing at least 80% of its assets in the securities that comprise the S&P MidCap? 400 Index ("index") and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index measures the performance of the mid-cap segment of the U.S. equity universe. The index is a capitalization-weighted index composed of 400 domestic common stocks. The fund is non-diversified.

Inception Date: 08/01/2009

Primary Benchmark: S&P MidCap 400 TR

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.99%

Management Expense Ratio: 1.10 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 0.35 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 12.12B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 6.36B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.09B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 4.11B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 3.82B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.21B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 1.14B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 1.01B
DPST Direxion Daily Regional Banks .. 1.02 %

N/A

USD 0.87B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 0.81B

ETFs Containing MIDU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.90% 67% D+ 91% A-
Dividend Return 0.67% 49% F 17% F
Total Return 26.56% 68% D+ 90% A-
Trailing 12 Months  
Capital Gain 29.13% 64% D 87% B+
Dividend Return 1.42% 51% F 20% F
Total Return 30.54% 65% D 86% B+
Trailing 5 Years  
Capital Gain 37.32% 57% F 67% D+
Dividend Return 2.84% 44% F 8% B-
Total Return 40.16% 57% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 33.40% 69% C- 91% A-
Dividend Return 33.85% 69% C- 90% A-
Total Return 0.45% 37% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 103.55% 34% F 7% C-
Risk Adjusted Return 32.69% 58% F 53% F
Market Capitalization 0.05B 50% F 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.